<--- Back to Details
First PageDocument Content
Cancer research / National Institutes of Health / Cancer organizations / Personalized medicine / Pharmacology / Comparative effectiveness research / Outcomes research / Alternative medicine / Health equity / Medicine / Health / Health economics
Date: 2014-04-03 23:57:10
Cancer research
National Institutes of Health
Cancer organizations
Personalized medicine
Pharmacology
Comparative effectiveness research
Outcomes research
Alternative medicine
Health equity
Medicine
Health
Health economics

FROM THE PRESIDENT SCIENCE POLICY BRIEF GUEST COLUMN

Add to Reading List

Source URL: www.personalizedmedicinecoalition.org

Download Document from Source Website

File Size: 2,59 MB

Share Document on Facebook

Similar Documents

Information science / Publishing / Citation metrics / Academic publishing / Library science / Bibliometrics / Citation indices / Clarivate Analytics / Web of Science / Citation analysis / Google Scholar / Scientometrics

Advanced Seminar: Assessment of Research and Teaching Outcomes at Higher Educa:on Ins:tu:ons Anne-Wil Harzing, www.Harzing.com

DocID: 1xTEv - View Document

Computing / Information / Data management / Data management plan / Open data / Big data / Data sharing / Open by default / Data mining / Data center / Data curation / Open science

REPORT OF THE EUROPEAN COMMISSION PUBLIC CONSULTATION ON OPEN RESEARCH DATA Executive summary and key outcomes The European Commission held a public consultation on open research data on 2 July 2013 in Brussels, which wa

DocID: 1xTtS - View Document

Research Ideas and Outcomes 3: e11825 doi: rio.3.e11825 Workshop Report Technical aspects of preprint services in the life

DocID: 1veDj - View Document

2009 年 英文 1. Yonemoto T, Kamibeppu K, Ishii T, Iwata S, Hagiwara Y, Tatezaki S. Psychosocial outcomes in long-term survivors of high-grade osteosarcoma: a Japanese single-center experience. Anticancer Research 2009

DocID: 1vaBn - View Document

EDITORIAL Draft National Health Policy of India and Determining Cost‑effectiveness Threshold The Seventh Asia‑Pacific Conference of the International Society for Pharmacoeconomics and Outcomes Research was held in

DocID: 1v9Se - View Document